Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Protamine Recombinant Human Insulin Injection (Premixed 50/50) in Type 1 or 2 Diabetes Mellitus
CTR20150616Phase 3Suspended
- Sponsor
- Hefei Tianhui Biotechnology
- Start
- Sep 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Insuman Comb 50 in diabetes mellitus type 1 (T1D), type 2 diabetes mellitus (T2DM), sponsored by Hefei Tianhui Biotechnology. Started Sep 2015; status: suspended.
02
Drugs
Insuman Comb 50
03
Conditions
diabetes mellitus type 1 (T1D)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20150616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150616.